Related Experiment Video
Updated: Jan 12, 2026

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
Rewriting the radiation playbook: NSABP B-51 and the rise of pathologic precision
Mehran Habibi1, Bruce G Haffty2, Silvia C Formenti3
1Division of Breast Surgery, Miami Cancer Institute, Baptist Health Cancer Care, Florida International University, Miami, USA. Mehran.Habibi@baptisthealth.net.
Abstract:
The NSABP B-51/RTOG 1304 trial represents a paradigm shift in breast cancer management, showing that patients achieving nodal clearance after neoadjuvant chemotherapy derive no added benefit from regional nodal irradiation. These results challenge long-standing practice, promotes de-escalation, and raise biologically significant questions, particularly regarding immunologic mechanisms and clinical subgroup variations.

